Clinical Trial Update: Modulation of the Immune Response in Patients With Pancreatic Tubular Adenocarcinoma [Phase 2]

View source ↗

Summary

Clinical trial update for a Phase 2 study on modulation of the immune response in patients with pancreatic cancer (pancreatic tubular adenocarcinoma). The statu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Snippet

Sponsor: Blood Transfusion Centre of Slovenia | Conditions: Pancreatic Tubular Adenocarcinoma | Phase 2 | Status: UNKNOWN